1. Home
  2. NVCR vs UMH Comparison

NVCR vs UMH Comparison

Compare NVCR & UMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • UMH
  • Stock Information
  • Founded
  • NVCR 2000
  • UMH 1968
  • Country
  • NVCR Switzerland
  • UMH United States
  • Employees
  • NVCR N/A
  • UMH N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • UMH Real Estate Investment Trusts
  • Sector
  • NVCR Health Care
  • UMH Real Estate
  • Exchange
  • NVCR Nasdaq
  • UMH Nasdaq
  • Market Cap
  • NVCR 1.4B
  • UMH 1.3B
  • IPO Year
  • NVCR 2015
  • UMH N/A
  • Fundamental
  • Price
  • NVCR $12.15
  • UMH $15.18
  • Analyst Decision
  • NVCR Buy
  • UMH Buy
  • Analyst Count
  • NVCR 7
  • UMH 2
  • Target Price
  • NVCR $28.79
  • UMH $20.25
  • AVG Volume (30 Days)
  • NVCR 1.3M
  • UMH 680.9K
  • Earning Date
  • NVCR 10-29-2025
  • UMH 11-05-2025
  • Dividend Yield
  • NVCR N/A
  • UMH 5.90%
  • EPS Growth
  • NVCR N/A
  • UMH N/A
  • EPS
  • NVCR N/A
  • UMH 0.13
  • Revenue
  • NVCR $630,160,000.00
  • UMH $250,046,000.00
  • Revenue This Year
  • NVCR $6.68
  • UMH $6.21
  • Revenue Next Year
  • NVCR $7.01
  • UMH $5.88
  • P/E Ratio
  • NVCR N/A
  • UMH $119.43
  • Revenue Growth
  • NVCR 14.58
  • UMH 8.49
  • 52 Week Low
  • NVCR $10.87
  • UMH $14.76
  • 52 Week High
  • NVCR $34.13
  • UMH $20.64
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 46.57
  • UMH 38.00
  • Support Level
  • NVCR $11.98
  • UMH $14.76
  • Resistance Level
  • NVCR $12.83
  • UMH $15.33
  • Average True Range (ATR)
  • NVCR 0.56
  • UMH 0.28
  • MACD
  • NVCR 0.15
  • UMH 0.01
  • Stochastic Oscillator
  • NVCR 25.49
  • UMH 32.56

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About UMH UMH Properties Inc.

UMH Properties Inc together with its subsidiaries is a real estate investment trust. It is engaged in the business of ownership and operation of manufactured home communities - leasing manufactured homesites to residents . The Company also leases manufactured homes to residents and, through its wholly-owned taxable REIT subsidiary, UMH Sales and Finance, Inc. sells and finances the sale of manufactured homes to residents and prospective residents of its communities and for placement on customers' privately-owned land. The company also owns the land, utility connections, streets, lighting, driveways, common area amenities, and other capital improvements. It earns income from lease agreements for their sites and homes, where the company is the lessor.

Share on Social Networks: